Cargando…
A Review of the Impact of Biologics on Surgical Complications in Crohn's Disease
Anti–tumor necrosis factor therapy has revolutionized the treatment of Crohn's disease. Despite the increased use in the past decade and a half, a majority of patients with Crohn's disease with ultimately require operative management of their disease. No clear consensus has been made in th...
Autores principales: | Chang, Melissa I., Cohen, Benjamin L., Greenstein, Alexander J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450910/ https://www.ncbi.nlm.nih.gov/pubmed/25811432 http://dx.doi.org/10.1097/MIB.0000000000000362 |
Ejemplares similares
-
Biologics and surgical outcomes in Crohn’s disease: is there a direct
relationship?
por: Quaresma, Abel Botelho, et al.
Publicado: (2020) -
Infliximab Combined with Enteral Nutrition for Managing Crohn's Disease Complicated with Intestinal Fistulas
por: Wu, Xiao-Li, et al.
Publicado: (2016) -
Biologics in Paediatric Crohn's Disease
por: Gouldthorpe, Oliver, et al.
Publicado: (2011) -
Surgical management of Crohn’s disease: a state of the art review
por: Meima - van Praag, Elise Maria, et al.
Publicado: (2021) -
Early versus delayed ileocolic resection for complicated Crohn’s disease: is “cooling off” necessary?
por: Peyser, Daniel K., et al.
Publicado: (2022)